Wasatch Advisors Inc. trimmed its holdings in Monsanto Company (NYSE:MON) by 63.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,479 shares of the basic materials company’s stock after selling 29,065 shares during the period. Wasatch Advisors Inc.’s holdings in Monsanto were worth $1,950,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also made changes to their positions in MON. BlackRock Inc. lifted its position in shares of Monsanto by 2,390.1% in the first quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock valued at $2,965,029,000 after acquiring an additional 25,140,936 shares in the last quarter. OZ Management LP purchased a new position in shares of Monsanto in the second quarter valued at about $242,786,000. York Capital Management Global Advisors LLC lifted its position in shares of Monsanto by 58.4% in the first quarter. York Capital Management Global Advisors LLC now owns 4,087,116 shares of the basic materials company’s stock worth $462,662,000 after buying an additional 1,506,057 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of Monsanto by 2,540.4% in the second quarter. Janus Henderson Group PLC now owns 1,491,324 shares of the basic materials company’s stock worth $176,515,000 after buying an additional 1,434,844 shares in the last quarter. Finally, PSquared Asset Management AG lifted its position in shares of Monsanto by 239.0% in the second quarter. PSquared Asset Management AG now owns 1,274,320 shares of the basic materials company’s stock worth $150,829,000 after buying an additional 898,395 shares in the last quarter. Institutional investors and hedge funds own 74.67% of the company’s stock.
Shares of Monsanto Company (MON) traded up 0.06% during mid-day trading on Friday, hitting $121.52. The stock had a trading volume of 1,809,877 shares. The firm has a market cap of $53.41 billion, a PE ratio of 23.88 and a beta of 1.07. The stock’s 50-day moving average is $119.82 and its 200 day moving average is $117.73. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $122.80.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The firm had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same period last year, the firm posted $0.07 EPS. Monsanto’s quarterly revenue was up 4.8% compared to the same quarter last year. Equities research analysts predict that Monsanto Company will post $5.70 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, October 6th were paid a $0.54 dividend. The ex-dividend date of this dividend was Thursday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.78%. Monsanto’s dividend payout ratio is currently 42.27%.
A number of equities research analysts recently commented on MON shares. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $131.00 target price on the stock in a research report on Tuesday, August 29th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective on the stock in a research note on Wednesday, July 12th. Piper Jaffray Companies set a $128.00 price objective on Monsanto and gave the stock a “buy” rating in a research note on Friday, August 11th. BMO Capital Markets reissued a “buy” rating and set a $128.00 price objective on shares of Monsanto in a research note on Friday, September 1st. Finally, Barclays PLC reaffirmed an “equal weight” rating and set a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Eleven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $124.61.
ILLEGAL ACTIVITY WARNING: “Wasatch Advisors Inc. Has $1.95 Million Stake in Monsanto Company (NYSE:MON)” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/28/monsanto-company-mon-shares-sold-by-wasatch-advisors-inc.html.
In other news, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $122.00, for a total value of $527,040.00. Following the transaction, the chief financial officer now owns 48,388 shares of the company’s stock, valued at approximately $5,903,336. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Brett D. Begemann sold 22,640 shares of Monsanto stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the transaction, the chief operating officer now directly owns 85,439 shares in the company, valued at $10,255,243.17. The disclosure for this sale can be found here. Insiders sold a total of 49,236 shares of company stock worth $5,931,934 in the last ninety days. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.